?
Wingrove Theresa
SVP OF REGULATORY AFFAIRS
ImmunoGen, Inc.
US, Waltham [HQ]
CIK
1510720
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
22,328
Price per Share :
$31.23
Equivalence :
$697,303.44
Transaction History
-
M22,328 Shares After TransactionValue : $237,793.20$207,856.05Transaction Date : 11/07/23
-
Footnotes
-
-
Footnotes:#1 Effected pursuant to a trading plan adopted on June 13, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.#2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $16.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
-
S2,811 Shares After TransactionValue : $46,831.26Sold $325,153.22Transaction Date : 11/07/23
-
Footnotes
-
-
Footnotes:#1 Effected pursuant to a trading plan adopted on June 13, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.#2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $16.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
-
M9,603 Shares After TransactionValue : $102,271.95$72,334.80Transaction Date : 11/29/23
-
Footnotes
-
-
Footnotes:#1 Effected pursuant to a trading plan adopted on June 13, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.#2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $16.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.#3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.80 to $29.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
-
S2,811 Shares After TransactionValue : $46,831.26Sold $113,154.72Transaction Date : 11/29/23
-
Footnotes
-
-
Footnotes:#1 Effected pursuant to a trading plan adopted on June 13, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.#2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $16.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.#3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.80 to $29.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
-
M136,502 Shares After TransactionValue : $1,453,746.30$1,423,809.15Transaction Date : 11/30/23
-
Footnotes
-
-
Footnotes:#1 Effected pursuant to a trading plan adopted on June 13, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.#2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $16.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.#3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.80 to $29.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.